Vimarsana
Biggest News Aggregation in the World

Page 3 - Jb Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jb Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jb Pharma Today - Breaking & Trending Today

Maharashtra GST dept inspects JB Pharma office, stock down 3% - Vimarsana News

Maharashtra GST dept inspects JB Pharma office, stock down 3%

 The inspection commenced on 25 October

Stocks in news: Coforge, RIL, Tata Communications, RattanIndia, Tata Motors - Vimarsana News

Stocks in news: Coforge, RIL, Tata Communications, RattanIndia, Tata Motors

Promoter Baring PE, through its affiliate Hulst BV, will likely sell its entire stake in IT services company Coforge through block deals on Thursday, according to reports.

Vehicle Thieves: Snatchers To Vehicle Thieves, 12 Held In A Wk After Gunfight | Noida News - Vimarsana News

Vehicle Thieves: Snatchers To Vehicle Thieves, 12 Held In A Wk After Gunfight | Noida News

Over the last one week, police have managed to nab at least a dozen criminals after gunfights across the district. This includes a thief who was caug

JB Pharma: Leap of faith: how Cipla veteran Nikhil Chopra got JB Pharma out of the woods, on to a growth path - Vimarsana News

JB Pharma: Leap of faith: how Cipla veteran Nikhil Chopra got JB Pharma out of the woods, on to a growth path

When PE firm KKR took control of JB Pharma in 2020, it was struggling for growth. Competitors had cornered the four legacy brands on which the company relied. Then, Nikhil Chopra, a seasoned hand from Cipla, took over. JB Pharmas subsequent turnaround is a tale of calculated risks, deft moves, and rebuilding. But the going gets tough from here.

We're targeting untapped potential in antibiotics, paediatrics and infertility, says JB Pharma's top exec - Vimarsana News

We're targeting untapped potential in antibiotics, paediatrics and infertility, says JB Pharma's top exec

In an interview with BT, Nikhil Chopra, CEO of JB Pharma, talks about the company’s plans to increase its revenues to Rs 6,000 crore